[go: up one dir, main page]

BR9910860A - Use of cyclosporins in the treatment of inflammatory autoimmune diseases - Google Patents

Use of cyclosporins in the treatment of inflammatory autoimmune diseases

Info

Publication number
BR9910860A
BR9910860A BR9910860-7A BR9910860A BR9910860A BR 9910860 A BR9910860 A BR 9910860A BR 9910860 A BR9910860 A BR 9910860A BR 9910860 A BR9910860 A BR 9910860A
Authority
BR
Brazil
Prior art keywords
treatment
cyclosporins
autoimmune diseases
inflammatory autoimmune
inflammatory
Prior art date
Application number
BR9910860-7A
Other languages
Portuguese (pt)
Inventor
Peter Hiestand
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR9910860A publication Critical patent/BR9910860A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Patente de Invenção: <B>"USO DE CICLOSPORINAS NO TRATAMENTO DE DOENçAS AUTO-IMUNES INFLAMATóRIAS"<D>. Ciclosporinas não-imunossupressivas que se ligam à ciclofilina, em particular [Melle]^ 4^-Ciclosporina, são úteis no tratamento e prevenção de doenças auto-imunes inflamatórias, tal como artrite reumatóide.Invention Patent: <B> "USE OF CYCLOSPORINS IN THE TREATMENT OF AUTO-IMMUNE INFLAMMATORY DISEASES" <D>. Non-immunosuppressive cyclosporins that bind cyclophilin, in particular [Melle] ^ 4 ^ -Cyclosporine, are useful in the treatment and prevention of inflammatory autoimmune diseases, such as rheumatoid arthritis.

BR9910860-7A 1998-06-02 1999-05-31 Use of cyclosporins in the treatment of inflammatory autoimmune diseases BR9910860A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9811854.0A GB9811854D0 (en) 1998-06-02 1998-06-02 Organic compounds
PCT/EP1999/003770 WO1999062540A1 (en) 1998-06-02 1999-05-31 Use of cyclosporins in the treatment of inflammatory autoimmune diseases

Publications (1)

Publication Number Publication Date
BR9910860A true BR9910860A (en) 2001-03-06

Family

ID=10833083

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9910860-7A BR9910860A (en) 1998-06-02 1999-05-31 Use of cyclosporins in the treatment of inflammatory autoimmune diseases

Country Status (17)

Country Link
EP (1) EP1082130A1 (en)
JP (2) JP4523154B2 (en)
KR (1) KR20010043969A (en)
CN (1) CN1304315A (en)
AU (1) AU750422B2 (en)
BR (1) BR9910860A (en)
CA (1) CA2333315A1 (en)
GB (1) GB9811854D0 (en)
HU (1) HUP0102142A3 (en)
ID (1) ID27576A (en)
IL (1) IL139589A0 (en)
NO (1) NO20006113L (en)
PL (1) PL344451A1 (en)
SK (1) SK18142000A3 (en)
TW (2) TWI250021B (en)
WO (1) WO1999062540A1 (en)
ZA (1) ZA200006464B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1123001A (en) 1999-10-27 2001-05-08 Alexandra Lucas Compositions and methods for preventing and treating transplant rejection
ATE453402T1 (en) * 2000-09-29 2010-01-15 Viron Therapeutics Inc USE OF SERP-1 IN COMBINATION WITH AN IMMUNOSUPPRESSOR TO TREAT ARTHRITIS
WO2004082629A2 (en) 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
GB0320638D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
JP2007532507A (en) * 2004-04-08 2007-11-15 ノバルティス アクチエンゲゼルシャフト Use of cyclosporine for the treatment of cerebral ischemia and brain and spinal cord injury
RU2394589C2 (en) 2004-07-14 2010-07-20 Новартис Аг Application of cyclosporine and pegylated interferon combination for hepatitis (hcv) treatment
JP2008514702A (en) 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド Novel cyclosporine analogues and their pharmaceutical use
US7378391B2 (en) 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
JP4892486B2 (en) * 2004-10-01 2012-03-07 デビオファーム ソシエテ アノニム Use of [D-MEALA] 3- [ETVAL] 4-cyclosporin for the treatment of hepatitis C infection and pharmaceutical composition comprising said [D-MEALA] 3- [ETVAL] 4-cyclosporin
US7361636B2 (en) 2004-10-06 2008-04-22 Amr Technology, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents
US7285530B2 (en) 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
KR20070087624A (en) 2004-12-23 2007-08-28 노파르티스 아게 Composition for the treatment of HBC
AU2005322241B2 (en) * 2004-12-23 2010-02-18 Novartis Ag Compounds for flaviviridae treatment
BRPI0613142A2 (en) * 2005-06-17 2010-12-21 Novartis Ag use of sangliferin in hcv
JP2007112775A (en) * 2005-10-24 2007-05-10 Hamamatsu Univ School Of Medicine Use of cyclosporines in the treatment of cytomegalovirus infection
US20090306033A1 (en) * 2008-06-06 2009-12-10 Keqiang Li Novel cyclic peptides
CN102083852A (en) * 2008-06-06 2011-06-01 西尼克斯公司 Cyclosporin analogs and their use in the treatment of HCV infections
JP5780969B2 (en) 2008-12-31 2015-09-16 サイネクシス，インコーポレーテッド Cyclosporine A derivative
US20110144005A1 (en) * 2009-12-09 2011-06-16 Scynexis, Inc. Novel cyclic peptides
CN104603146B (en) 2012-09-29 2018-01-02 诺华股份有限公司 Cyclic peptide compound and its purposes as medicine
US20140212381A1 (en) * 2012-10-19 2014-07-31 Scynexis, Inc. Macrocycles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2095926T5 (en) * 1990-11-02 2001-02-16 Novartis Ag CYCLOSPORINS
AR006514A1 (en) * 1995-07-04 1999-09-08 Sandoz Ag A MACROLID, ITS USES, A PROCESS TO PRODUCE IT, A BIOLOGICALLY PURE ISOLATE CAPABLE OF PRODUCING IT, AND A PHARMACEUTICAL COMPOSITION THAT IT INCLUDES
US6124453A (en) * 1995-07-04 2000-09-26 Novartis Ag Macrolides
CZ288631B6 (en) * 1996-01-18 2001-08-15 Galena, A. S. Therapeutic preparations containing cyclosporin
CZ288739B6 (en) * 1996-08-01 2001-08-15 Galena, A. S. Cyclosporin containing medicinal preparations

Also Published As

Publication number Publication date
HUP0102142A2 (en) 2001-11-28
SK18142000A3 (en) 2001-06-11
KR20010043969A (en) 2001-05-25
AU750422B2 (en) 2002-07-18
GB9811854D0 (en) 1998-07-29
NO20006113L (en) 2001-01-25
IL139589A0 (en) 2002-02-10
HUP0102142A3 (en) 2001-12-28
JP2010059177A (en) 2010-03-18
TWI250022B (en) 2006-03-01
CN1304315A (en) 2001-07-18
NO20006113D0 (en) 2000-12-01
ZA200006464B (en) 2002-03-11
WO1999062540A1 (en) 1999-12-09
AU4372499A (en) 1999-12-20
ID27576A (en) 2001-04-12
TWI250021B (en) 2006-03-01
JP2002516873A (en) 2002-06-11
EP1082130A1 (en) 2001-03-14
JP4523154B2 (en) 2010-08-11
CA2333315A1 (en) 1999-12-09
TW200522975A (en) 2005-07-16
PL344451A1 (en) 2001-11-05

Similar Documents

Publication Publication Date Title
BR9910860A (en) Use of cyclosporins in the treatment of inflammatory autoimmune diseases
BR9911724A (en) Cyclosporine that has an improved activity profile
DE69731373D1 (en) CC CHEMOKINCEPTOR C-C CKR-5, THEIR DERIVATIVES AND USES
BR0114390A (en) 7-desmethylrapamycin ethers
DE69936778D1 (en) ADENOASSOZED VIRUS VECTORS AND ITS USES
EA200100519A1 (en) COMPOSITIONS ON THE BASIS OF A FINE-GROUNDED EPLERENON
DE50306232D1 (en) AMPHOLYTIC COPOLYMER AND ITS USE
DK1131065T3 (en) Diacyl dumarates for the treatment of autoimmune diseases
ES2190246T3 (en) NEW THIAZOLOPIRIMIDINE COMPOUNDS.
NO964966D0 (en) Lactobacillus strains of human origin, mixtures and their use
EA200000381A1 (en) PREPARATION OF 2-METHYL-TIENO-BENZODIAZEPINA
AU3227700A (en) Skin sanitizing compositions
ATE272628T1 (en) SUBSTITUTED GAMMA-PHENYL-DELTA-LACTONES AND ANALOGUES THEREOF, AND USES THEREOF
CA2139725A1 (en) Endoparasiticidal compositions
BR9402890A (en) Composition of siloxane-based lubricant in the hydrogen segregator.
TR200100462T2 (en) Muscarinic agonists and antagonists
BR0009767A (en) Osteopontin-derived inhibitory and chemotactic agents and their uses
ES2172703T3 (en) PERFLUORO FLUORIDE COMPOSITIONS (ALCANO ALCOXICICLO) CARBONILO, AND ITS USE.
ATE305517T1 (en) NEUROTRYPSIN
UA48245C2 (en) SUBSTITUTED-2-AMINO-1,2,3,4-TETRAHYDRODIBENZOFURANS AND 2-AMINOCYCLOHEPTA[b]BENZOFURANS USEFUL AS 5-HT1F AGONISTS IN MAMMALS, PHARMACEUTICAL FORMULATION
EP1082126A4 (en) Novel peptides
WO2002000686A3 (en) Bioelastomer nanomachines and biosensors
BR9909252A (en) Caspase-8 interaction proteins
ATE398188T1 (en) DNA VACCINES ENCODING ACCESSORY HIV PROTEINS
BR9914722A (en) Anticonvulsant derivatives useful in the treatment of alcohol dependence, addiction and abuse

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.